Araştırma makaleleri

 

  1. Turkmen S, Dogan S, Barutcu I, Sipahi I, Ayabakan H, Esen AM, Esen O, Guzelsoy D. The changes in circulating levels of vasoactive intestinal polypeptide during exercise and its reproducibility for detection of myocardial ischemia. Int Heart J 2005;46:363-71.

  2. Tekin G, Tekin A, Sipahi I, Kaya A, Sansoy V. Plasma concentration of soluble vascular cell adhesion molecule-1 and oncoming cardiovascular risk in patients with unstable angina pectoris and non-ST-segment elevation myocardial infarction. Am J Cardiol 2005;96:379-81.

  3. Nicholls SJ, Tuzcu EM, Schoenhagen P, Sipahi I, Crowe T, Kapadia S, Nissen SE. Effect of Atorvastatin (80 mg daily) – vs – Pravastatin (40 mg daily) on Arterial Remodeling at Coronary Branch Points (From the REVERSAL Study). Am J Cardiol 2005; 96: 1636-9.

  4. Ozduran V, Yamani MH, Chuang HH, Sipahi I, Cook DJ, Sendrey D, Tong L, Hobbs R, Rincon G, Bott-Silverman C, James K, Taylor DO, Young JB, Navia J, Banbury M, Smedira N, Starling RC. Survival beyond 10 years following heart transplantation: The Cleveland Clinic Foundation experience. Transplant Proc 2005;37:4509-12.

  5. Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Kapadia S, Nissen SE: Paradoxical Increase in Lumen Size During Progression of Coronary Atherosclerosis: Observations from The REVERSAL Trial. Atherosclerosis 2006 Jan 19; [Epub ahead of print]

  6. Nicholls SJ, Tuzcu EM, Sipahi I, Schoenhagen P, Crowe T, Kapadia S and Nissen SE. Relationship between Atheroma Regression and Change in Lumen Size Following Infusion of Apolipoprotein A-I Milano. J Am Coll Cardiol 2006;47:992-7.

  7. Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Ozduran V, Kapadia S, Nissen SE: Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: Serial intravascular ultrasound observations from the REVERSAL trial. Eur Heart J 2006;27:1664-70.

  8. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, Schoenhagen P, Waters DD, Pepine CJ, Crowe TD, Davidson MH, Deanfield JE, Wisniewski LM, Hanyok JJ, Kassalow LM; ACAT Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) investigators. Effect of ACAT inhibition on the progression of coronary atherosclerosis. New Engl J Med 2006;354:1253-63.

  9. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID Trial. JAMA 2006; 295:1556-65.

  10. Nicholls SJ, Sipahi I, Schoenhagen P, Wisniewski L, Churchill T, Crowe T, Goormastic M, Wolski K, Tuzcu EM, Nissen SE. Intravascular Ultrasound Assessment of Novel Anti-Atherosclerotic Therapies: Rationale and Design of the ACAT Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study. Am Heart Journal 2006;152:67-74.

  11. Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Crowe T, Kapadia S, Nissen SE. Discordance between Static and Serial Assessments of Arterial Remodeling: An Intravascular Ultrasound Analysis from the Reversal of Atherosclerosis with Aggressive Lipid Lowering  (REVERSAL) Trial. Am Heart Journal 2006 152:544-50.

  12. Nicholls SJ, Nissen SE, Tuzcu EM, Crowe T, Sipahi I, Schoenhagen P, Kapadia S, Hazen SL, Wun, C, Norton M, Ntanios F, Nissen SE. Relationship between Cardiovascular Risk Factors and Atherosclerotic Disease Burden Measured by Intravascular Ultrasound. J Am Coll Cardiol 2006;47:1967-75.

  13. Nicholls SJ, Tuzcu EM, Sipahi I, Schoenhagen P, Hazen SL, Ntanios F, Wun C, Nissen SE. Effects of obesity on lipid lowering, anti-inflammatory and anti-atherosclerotic benefits of atorvastatin and pravastatin in patients with coronary artery disease (From the REVERSAL study). Am J Cardiol 2006; 97:1553-7.

  14. Schoenhagen P, Tuzcu EM, Apperson-Hansen C, Wang C, Sipahi I, Nicholls SJ, Magyar WA, Loyd A, Churchill T, Crowe T, Nissen SE. Determinants of Arterial Wall Remodeling during Lipid Lowering Therapy. Serial IVUS Observations from the REVERSAL Trial. Circulation 2006;113:2826-34.

  15. Sipahi I, Tuzcu EM, Schoenhagen P, Wolski K, Nicholls SJ, Balog C, Crowe T, Nissen SE. Effects of Normal, Prehypertensive and Hypertensive Blood Pressure Levels on Progression of Coronary Atherosclerosis. J Am Coll Cardiol 2006;15;48(4):833-8.

  16. Tekin G, Tekin A, Canatar T, Sipahi I, Unsal A, Katircibasi T, Kocum T, Erol T, Yigit F, Demircan S, Ermis N, Sezgin AT, Muderrisoglu H. Simvastatin improves the attenuated heart rate recovery of type 2 diabetics. Pharmacol Res 2006:54:442-6.

  17. Nicholls SJ, Tuzcu EM , Wolski K, Sipahi I, Schoenhagen P, Crowe T, Kapadia S, Hazen S, Nissen SE. Coronary Artery Calcification and Atherosclerotic Plaque Progression in Response to Established Medical Therapies. J Am Coll Cardiol 2007;49:263-70.

  18. Nicholls SJ, Tuzcu EM ,  Sipahi I, Grasso AW Schoenhagen P, Hu T, Wolski K,  Crowe T, Dedai, Hazen S, Kapadia S, Nissen SE. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 2007;297:499-508.

  19. Nicholls SJ, Tuzcu EM, Hsu A, Wolski K, Sipahi I, Schoenhagen P, Crowe T, Kapadia SR, Hazen SL, Nissen SE. Comparison of coronary atherosclerotic volume in patients with glomerular filtration rates < or = 60 versus > 60 ml/min/1.73 m2: a meta-analysis of intravascular ultrasound studies. Am J Cardiol 2007;99:813-6.

  20. Nicholls SJ, Wolski K, Sipahi I, Schoenhagen P, Crowe T, Kapadia SR, Hazen SL, Tuzcu EM, Nissen SE. Rate of progression of coronary atherosclerotic plaque in women. J Am Coll Cardiol 2007;49:1546-51.

  21. Sipahi I, Tuzcu EM, Wolski KE, Nicholls SJ, Schoenhagen P, Balog C, Magyar WA, Crowe T, Kapadia S, Nissen SE. Beta-Blockers and Progression of Coronary Atherosclerosis: A Pooled Analysis from Four Intravascular Ultrasound Trials. Ann Intern Med 2007;147:10-8.

  22. Baris N, Sipahi I, Kapadia SR, Nicholls SJ,  Erinc K, Gulel O, Crowe TD, Hobbs R, Yamani MH, Taylor DO, Smedira N, Starling RC, Nissen SE and Tuzcu EM. Coronary angiography for follow-up of heart transplant recipients: Insights from TIMI frame count and TIMI myocardial perfusion grade. J Heart Lung Transplant 2007;26:593-7.

  23. Sipahi I, Tuzcu EM, Moon KW, Nicholls S, Schoenhagen P, Zhitnik J, Crowe T, Kapadia S, Nissen S. Do the extent and direction of arterial remodeling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study.  Heart 2008;94:623-7.

  24. Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, Schoenhagen P, Nissen SE. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 2008;52:255-62.

  25. Chhatriwalla AK, Nicholls SJ, Wang TH, Wolski K, Sipahi I, Crowe T, Schoenhagen P, Kapadia S, Tuzcu EM, Nissen SE .Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis. J Am Coll Cardiol  2009; 53:1110-5.

  26. Sipahi I , Debanne SM, Rowland DY, Simon DI, Fang JC .Angiotensin Receptor Blockade and Risk of Cancer: Meta-Analysis of Randomised Controlled Trials. Lancet  Oncology 2010:11:627-36.

  27. Wiktor DM, Sawlani N, Kanthi Y, Sipahi I, Fang JC, Blitz A. Successful Combined Use of Impella Recover 2.5 Device and Intra-Aortic Balloon Pump Support in Cardiogenic Shock from Acute Myocardial Infarction. ASAIO J 2010;56:519-21.

  28. Sipahi I , Carrigan TP, Rowland DY, Stambler BS, Fang JC.  Impact of QRS Duration on Clinical Event Reduction with Cardiac Resynchronization Therapy: A Meta-Analysis of Randomized Controlled Trials . Arch Intern Med  2011 Sep 12;171(16):1454-62. Epub 2011 Jun 13.

  29. Sipahi I, Chou J, Mishra P, Debanne SM, Simon DI, Fang JC. Meta-Analysis of Randomized Controlled Trials on Effect of Angiotensin-Converting Enzyme Inhibitors on Cancer Risk. Am J Cardiol 2011 Jul 15;108(2):294-301. Epub 2011 May 19

  30. Sipahi I, Swaminathan A, Natesan V, Debanne SM, Simon DI, Fang JC. Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials. Stroke  2012 Feb; 43(2):432-40. Epub 2011 Dec 8.

  31. Sipahi I, Chou JC, Hyden M, Rowland DY, Simon DI, Fang JC. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials. Am Heart J. 2012 Feb;163(2):260-267.e3.

  32. Chow CH, El-Amm C, Liu W, Pastva S, Sipahi I, Fang JC. Reversal of severe biventricular dysfunction from cardiac hemochromatosis with iron removal. Circ Heart Fail. 2013 Jan 1;6(1):e14-5. doi: 10.1161/CIRCHEARTFAILURE.112.971747.

  33. Degirmencioglu A, Karakus G, Güvenc TS, Pinhan O, Sipahi I, Akyol A. Echocardiography-guided or "sided" pericardiocentesis. Echocardiography.  2013 Oct;30(9):997-1000.

  34. Degirmencioglu A, Karakus G, Buturak A, Cakmak N, Sipahi I, Akyol A. Electrophysiologic Effects of the Statins in Patients with Ischemic Cardiomyopathy and Ventricular Tachyarrhythmia. Kuwait Medical Journal 2013; 45 (4): 307-12.

  35. Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel Disease. JAMA Internal Medicine DOI:10.1001/ jamainternmed2013.12844

  36. Sipahi I, Chaudhry SS, Issa M, Ambati M, Dagdelen S, Fang JC. Impact of QRS duration on survival benefit with prophylactic implantable cardioverter-defibrillators: a meta-analysis of randomized controlled trials. J Cardiovasc Med (Hagerstown). 2014 Jul 10. [Epub ahead of print]

  37. Sipahi I, Tekin G, Yigit Z, Guzelsoy D, Guven O: Quinapril Improves the Attenuated Heart Rate Recovery of Type 2 Diabetic Subjects without Known Coronary Artery Disease. Clin Cardiol  2004;27:480-484.

  38. Okcun EOB, Sipahi I, Kucukoglu S, Kucukoglu H, Baran T: Incidence of cerebral ischemic events in patients with atrial septal aneurysm. Neurologia Croatica 2004;53:5-12.

Davetli makaleler

 

  1. Nicholls SJ, Sipahi I, Tuzcu EM. Assessment of Progression and Regression of Coronary Atherosclerosis by Intravascular Ultrasound. A New Paradigm Shift? Rev Esp Cardiol 2006;59:57-66.

  2. Sipahi I, Nicholls SJ, Tuzcu EM. Recent trends in coronary intravascular ultrasound: tracking atherosclerosis, pursuit of vulnerable plaques and beyond. J Nuclear Cardiol 2006;13:91-6.

  3. Nicholls SJ, Sipahi I, Schoenhagen P. The ACTIVATE study: lessons for the future of atherosclerotic therapy. Future Lipidology 2006,1:421-428.

  4. Sipahi I, Nicholls SJ, Tuzcu EM. Intravascular Ultrasound in the Current Percutaneous Coronary Intervention Era. Cardiol Clinics 2006;24:163-73.

  5. Nicholls SJ, Sipahi I. Emerging Role of Intravascular Ultrasound in the Assessment of Experimental Anti-Atherosclerotic Therapies. Clin Med Chem 2006;13:1727-34.

  6. Nicholls SJ, Sipahi I, Schoenhagen P, Crowe T, Tuzcu EM, Nissen SE. Application of intravascular ultrasound in anti-atherosclerotic drug development. Nat Rev Drug Dis 2006;5:485-92.

  7. Sipahi I, Nicholls SJ, Tuzcu EM, Nissen SE. Coronary atherosclerosis can regress with very intensive statin therapy. Cleve Clin J Med 2006;73:937-44.

  8. Sipahi I, Starling RC. Cardiac Allograft Vasculopathy: An Update. Heart Failure Clin 2007;3:87-95.

  9. Gulel O, Sipahi I, TuzcuEM. Intravascular Ultrasound: Questions and Answers. Anadolu Kardiyol Derg 2007;7:169-78.

  10. Schoenhagen P, Sipahi I. Arterial remodelling: an independent pathophysiological component of atherosclerotic disease progression and regression. Insights from serial pharmacological intervention trials. Eur Heart J 2007;28:2299-300.

  11. Sipahi I, Tuzcu EM. Candidate Mechanisms for Regression of Coronary Atherosclerosis with High-Dose Statins: Insight from Intravascular Ultrasonography Trials.   Am J Cardiovasc Drugs 2008;8:365-71.

  12. Sipahi I, Fang JC. Treating Heart Failure on Dialysis: Finally Getting Some Evidence.   J Am Coll Cardiol 2010;56:1709–11.

  13. Baibars M, Ibrahim A, Fang JC, Sipahi I. Natriuretic peptide-guided management of patients with heart failure: a decade of progress but still a controversy. Future Cardiol. 2010;6:743-7.

  14. Oghlakian GO, Sipahi I, Fang JC. Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm? Mayo Clin Proc 2011;86:531-9.

  15. Sipahi I, Fang JC. CRT should be reserved for a QRS duration ≥150 ms: pro. Circ Arrhythm Electrophysiol. 2013 Apr;6(2):436-42.

  16. Sipahi I . Bypass Grafting versus Percutaneous Intervention in Multivessel Coronary Disease: The Current State. Curr Cardiol Clin 2015 Curr Cardiol Rep. 2015 Feb;17(2):558.

     

     

     

     

     

     

     

     

     

  1. Sipahi I. Letter to the editor about the March 2003 issue of the Anatolian Journal of Cardiology. Anadolu Kardiyol Derg. 2003;3:186.

  2. Sipahi I, Tuzcu EM. Letter to the editor for "LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients: an intravascular ultrasound study" Eur Heart J 2006; Mar 14; [Epub ahead of print] 

  3. Nicholls SJ, Sipahi I. Letter to the editor for “Studying coronary plaque regression with IVUS: a critical review of recent studies.” J Interv Cardiol 2006;19:345.

  4. Gulel O, Sipahi I, Tuzcu EM, Kapadia S. Coronary artery wall enhances with intracoronary injection of echocontrast media during in vivo intravascular ultrasound. Eur J Echocardiogr. 2006 Sep 28; [Epub ahead of print]

  5. Sipahi I, Tuzcu EM, Nissen SE. Effects of Normal, Pre-Hypertensive, and Hypertensive Blood Pressure Levels on Progression of Coronary Atherosclerosis: Reply. J Am Coll Cardiol 2007 Mar;49:1369-1370.

  6. Sipahi I, Nissen SE. Response to letter. Beta-Blockers and Progression of Coronary Atherosclerosis: A Pooled Analysis from Four Intravascular Ultrasound Trials. Ann Intern Med  2008;148:404-5.

  7. Fang JC, Sipahi I. Rate or Rhythm Control for Atrial Fibrillation in Patients with Systolic Heart Failure. Updates: Hurst's The Heart, 12e. 8/2008, uRL: www.accessmedicine.com/updatesContent.aspx?aID=1001342

  8. Sipahi I, Fang JC. Clinical Acumen Still Matters:  Use of Brain Natriuretic Peptide Levels in the Management of Heart Failure and The TIME-CHF Trial. Updates: Hurst's The Heart, 12e.

  9. Carrigan TP, Sipahi I. Cardiac-resynchronization therapy. N Engl J Med  2010 Jan 14;362(2):177

  10. Oghlakian G, Sipahi I, Fang JC. Treating “Diastolic Heart Failure”: Have we made any progress? Updates: Hurst's The Heart, 12e.July 21, 2010. www.accessmedicine.com/updatesContent.aspx?aid=1001645

  11. Sipahi I, Simon DI, Fang JC. Angiotensin-receptor blockade, cancer, and concerns - Authors' reply. Lancet Oncol. 2010;11:821-2.

  12. Sipahi I. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Authors' reply. Arch Intern Med  2012 Feb 27;172(4): 375-6.

  13. Sipahi I. Uzman Yanıtları. Akut kalp yetersizliği tedavisinde levosimendanı hangi hastalarda kullanıyorsunuz? Türk Kardiyol Dern Arş - Arch Turk Soc Cardiol 2013;41(1):95-96.

  14. Sipahi I, Celik S, Akyol A. Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials. J Am Coll Cardiol.2013 Sep 3;62(10):945-6.

  15. Sipahi I, Celik S, Tozun N. A Comparison of Results of the US Food and Drug Administration's Mini-Sentinel Program With Randomized Clinical Trials: The Case of Gastrointestinal Tract Bleeding With Dabigatran. JAMA Intern Med. 2013 Nov 18. doi: 10.1001/jamainternmed.2013.12217.

  16. Sipahi I. Coronary artery bypass grafting vs percutaneous coronary intervention in multivessel disease--reply. JAMA Intern Med. 2014 Jun; 174(6):1007-8

     

     

     

     

     

     

     

     

     

Diğer makaleler
Kongre Bildirileri (seçilmiş)

 

  1. Ozkan AA, Pehlivanoglu S, Zungur M, Dogan S, Batukan O, Sipahi I, Enar R. Risk profile of young women with myocardial infarction. 3rd International Congress on Coronary Artery Disease Oct 2-5, 2000, Lyon, France. p26.

  2. Batukan  O, Ozkan AA, Pehlivanoglu S, Sipahi I, Dogan S, Binici G, Enar R. Clinical importance of persistent ST-T elevation in the early perioid after acute myocardial infarction. 3rd International Congress on Coronary Artery Disease, Lyon, France, Oct 2-5, 2000, p58.

  3. Sayar N, Ozkan AA, Pehlivanoglu S, Binici G, Batukan O, Sipahi I, Enar R. Circadian variation of QTCD in acute myocardial infarction. 3rd International Congress on Coronary Artery Disease, Lyon, France, Oct 2-5, 2000. p58.

  4. Ozkan AA, Pehlivanoglu S, Sipahi I, Binici G, Batukan O, Gunes Y, Enar R. The effect of intraaortic balloon pump support in the patency of the infarct related artery and infarct size in cases of acute myocardial infarction treated with thrombolytic therapy. 3rd International Congress on Coronary Artery Disease, Lyon, France, Oct 2-5, 2000. p120.

  5. Ozkan AA, Pehlivanoglu S, Batukan O, Binici G, Hasdemir H, Sipahi I, Enar R. The role of cTnT positivity in predicting response to thrombolytic therapy. 3rd International Congress on Coronary Artery Disease, Lyon, France, Oct 2-5, 2000. p145.

  6. Erdogan I, Orta K, Ozkan AA, Pehlivanoglu S, Sipahi I, Binici G, Enar R. Clinical characteristics and short term prognosis of non-q wave acute myocardial infarction with ST segment elevation or ST segment depression. 3rd International Congress on Coronary Artery Disease, Lyon, France, Oct 2-5, 2000. p175.

  7. Yildiz A, Ozkan AA, Pehlivanoglu S, Sipahi I, Binici G, Okuyan E, Enar R. The relationship between high troponin- T levels and early prognosis in unstable angina. 3rd International Congress on Coronary Artery Disease, Lyon, France, Oct 2-5, 2000. p175.

  8. Sipahi I, Tekin G, Yigit Z, Guzelsoy D, Guven O. Quinapril improves the attenuated heart rate recovery of type 2 diabetic subjects without known coronary artery disease. Circulation 2003;108 (Suppl.):701. 2003 American Heart Association Scientific Sessions.

  9. Sipahi I, Schoenhagen P, Nicholls SJ, Crowe T, Hansen D, Loyd A, Kapadia S, Tuzcu EM, Nissen SE: Cross-Sectional Versus Serial Assessment of Coronary Arterial  Remodeling in Mildly Stenotic Atherosclerotic Lesions Undergoing Progression: An Intravascular Ultrasound Study. J Am Coll Cardiol 2005; 45(suppl): 69A. American College of Cardiology Annual Scientific Sessions.

  10. Sipahi I, Schoenhagen P, Nicholls SJ, Crowe T, Magyar W, Churchill T, Kapadia S, Tuzcu EM, Nissen SE: Regression of Coronary Atherosclerotic Plaque Is Commonly Associated With Constrictive Arterial Remodeling: A Serial Intravascular Ultrasound Study. J Am Coll Cardiol 2005; 45(suppl): 437A. American College of Cardiology Annual Scientific Sessions.

  11. Nicholls SJ, Sipahi I, Schoenhagen P, Crowe T, Kapadia S, Nissen SE; Tuzcu EM:Infusion of Recombinant ApoA-I Milano Promotes Reverse Remodeling of Coronary Atherosclerotic Lesions. J Am Coll Cardiol 2005; 45(suppl): 60A. American College of Cardiology Annual Scientific Sessions.

  12. Nicholls SJ, Schoenhagen P, Sipahi I, Crowe T, Kapadia S, Nissen SE; Tuzcu EM: An Intensive Lipid-Lowering Strategy Halts Progression of Atherosclerosis at Coronary Arterial Branch Points. J Am Coll Cardiol 2005; 45(suppl): 59A. American College of Cardiology Annual Scientific Sessions.

  13. Chen MS, Wun C, Sipahi I, Lee D, Schoenhagen P, Tuzcu EM, Brener S, Nissen S: Relationship Between Angiographic Extent of Coronary Artery Disease and Severity of Plaque Burden by Intravascular Ultrasound. J Am Coll Cardiol 2005; 45(suppl): 60. American College of Cardiology Annual Scientific Sessions.

  14. Chen MS, Wun C, Sipahi I, Lee D, Schoenhagen P, Tuzcu EM, Brener S, Nissen S: Extent of Angiographic Disease Predicts Response to Statin Therapy. J Am Coll Cardiol 2005; 45(suppl): 68A. American College of Cardiology Annual Scientific Sessions.

  15. Sipahi I, Schoenhagen P, Nicholls SJ, Ozduran V, Kapadia S, Nissen SE, Tuzcu EM. Coronary arteries retain their capacity for compensatory remodeling beyond cross-sectional area stenosis of 40%: a serial intravascular ultrasound study. Eur Heart J 2005; 26 (suppl):474. European Society of Cardiology Annual Meeting.

  16. Sipahi­ I, Tuzcu EM, Chen MS, Crowe T, Ozduran V, Brener SJ, Schoenhagen P, Nissen SE. Quantitative angiography correlates with cross-sectional atheroma burden but not with the longitudinal extent of disease: An intravascular ultrasound study of mildly stenotic coronaries. Eur Heart J 2005; 26 (suppl):716. European Society of Cardiology Annual Meeting.

  17. Sipahi I, Tuzcu EM, Nicholls SJ, Schoenhagen P, Chen MS, Crowe T, Magyar WA, Kapadia S, Nissen SE. Effects of blood pressure components on progression of coronary atherosclerosis: A two-year intravascular ultrasound study Circulation 2005 112 (Suppl): U572-U573. 2005 American Heart Association Scientific Sessions.

  18. Nicholls SJ, Brennan ML, Sipahi I, Schoenhagen P, Churchill T, Kapadia SR, Tuzcu EM, Nissen SE, Hazen SL. Traditional cardiac risk factors and myeloperoxidase levels: Correlation with coronary atherosclerotic plaque burden determined by intravascular ultrasound. Circulation 2005 112(Suppl): U679 . 2005 American Heart Association Scientific Sessions.

  19. Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Chen MS, Kapadia S, Nissen SE. Changes in lumen size during progression and regression of coronary atherosclerosis: Serial intravascular ultrasound observations from the REVERSAL trial. Circulation 2005 112(Suppl): U727. 2005 American Heart Association Scientific Sessions.

  20. Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Ozduran V, Kapadia S, Nissen SE. Coronary arterial remodeling is unrelated to atheroma burden: Observations form the REVERSAL study. Arch Turkish Soc Cardiol  2005;33(suppl 1):20. Turkish Society of Cardiology 2005 National Cardiology Congress.

  21. Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Crowe T, Magyar WA, Kapadia S, Nissen SE. Blood pressure components and progression of coronary atherosclerosis: An intravascular ultrasound study. Arch Turkish Soc Cardiol  2005;33(suppl 1):68. Turkish Society of Cardiology 2005 National Cardiology Congress.

  22. Sipahi I, Gulel O, Karha J, Nissen SE, Tuzcu EM, Kapadia S. Enhancement of coronary arterial wall after injection of intracoronary echocontrast: An in vivo intravascular ultrasound study. Arch Turkish Soc Cardiol  2005;33(suppl 1):117. Turkish Society of Cardiology 2005 National Cardiology Congress.

  23. Schoenhagen P, Tuzcu EM, Apperson-Hansen C,  Sipahi I, Nicholls S, Magyar WA, Loyd A, Churchill T, Crowe T, SE Nissen.  Determinants of Arterial Wall Remodeling During Lipid Lowering Therapy. Serial IVUS Observations from the REVERSAL Trial. J Am Coll Cardiol 2006; 47(suppl A): 320A. American College of Cardiology Annual Scientific Sessions.

  24. Sipahi I, Tuzcu EM, Nicholls SJ, Gulel O, Wolski KE, Frid DJ, Shi H, Kapadia S, Schoenhagen P, Nissen SE. Effects of Optimal Versus High Normal Blood Pressure on Progression of Coronary Atherosclerosis: Insight From the CAMELOT Study. J Am Coll Cardiol 2006; 47(suppl A):343A. American College of Cardiology Annual Scientific Sessions.

  25. Nicholls SJ, Sipahi I, Schoenhagen P, Thompson P, Frid D, Shi H, Thakker KM, Tuzcu EM, Nissen SE. Impact of Gender on the Clinical Benefit of Anti-hypertensive Therapy in Patients With Coronary Artery Disease and Normal Blood Pressure. J Am Coll Cardiol 2006; 47(suppl A):372A. American College of Cardiology Annual Scientific Sessions.

  26. Nicholls SJ, Sipahi I, Schoenhagen P, Thompson P, Frid D, Shi H, Thakker KM, Tuzcu EM, Nissen SE. Older Patients Receive the Greatest Benefit From the Initiation of Anti-hypertensive Agents in the Setting of Coronary Artery Disease and Normal Blood Pressure J Am Coll Cardiol 2006; 47(suppl A):209A. American College of Cardiology Annual Scientific Sessions.

  27. Sipahi I, Tuzcu EM, Nicholls SJ, Schoenhagen P,  Gulel O, Loyd AB, Churchill T, Kapadia S, Nissen SE,  Use of Beta-Blockers and Progression of Coronary Atherosclerosis: An Intravascular Ultrasound Analysis from the CAMELOT Study. J Am Coll Cardiol 2006; 47(suppl A): 320A, American College of Cardiology Annual Scientific Sessions.

  28. Nicholls SJ, Wolski K, Wang T, Chhatriwalla A, Sipahi I, Schoenhagen P, Crowe T, Kapadia S, Tuzcu EM, Nissen SE, Aggressive Modification of Risk Factors Promotes Regression of Coronary Atherosclerosis in Patients With Diabetes. J Am Coll Cardiol 2006; 47(suppl B): 27B. American College of Cardiology Annual Scientific Sessions.

  29. Nicholls SJ, Wolski K, Sipahi I, Schoenhagen P, Crowe T, Kapadia S, Hazen SL, Tuzcu EM, Nissen SE. Patients With More Coronary Calcification Undergo Less Change in Atheroma Burden With Established Medical Therapies: Observations From Intravascular Ultrasound. J Am Coll Cardiol 2006; 47(suppl B):27B. American College of Cardiology Annual Scientific Sessions.

  30. Sipahi I, Gulel O, Karha J, Nicholls SJ, Nissen SE, Tuzcu EM, Kapadia S. Enhancement of Coronary Artery Wall with Intracoronary Injection of Echo Contrast Media: An In Vivo Intravascular Ultrasound Study. Eur Heart J 2006; 27 (suppl):368. European Society of Cardiology Annual Meeting.

  31. Sipahi I, Tuzcu EM, Schoenhagen P, Gulel O, Kapadia S, Nicholls SJ, Zhitnik J, Nissen SE. Does Arterial Remodeling Predict Subsequent Progression of Coronary Atherosclerosis? Insight from the REVERSAL Study. Eur Heart J 2006; 27 (suppl):699. European Society of Cardiology Annual Meeting.

  32. Nicholls SJ, Sipahi I, Andrews J, Wolski K, Schoenhagen P, Crowe Y, Desai, Tuzcu EM, Nissen SE. Proatherogenic Impact of the ACAT Inhibitor Pactimibe in Patients with Coronary Artery Disease and Multiple Risk Factors: Insights from thE ACTIVATE study. Circulation 2006;114 (suppl): II-224. 2006 American Heart Association Scientific Sessions.

  33. Chhatriwalla AK, Wang TH, Wolski K, Sipahi I, Crowe TD, Schoenhagen P, Kapadia SR, Tuzcu EM, Nissen SE, Nicholls SJ. Optimal Control of Both lipids and BloodPressureis Required for Maximal Regression of Coronary Atherosclerosis. Circulation 2006;114 (suppl): II-795. 2006 American Heart Association Scientific Sessions.

  34. Sipahi I, Tuzcu EM, Wolski KE, Nicholls SJ, Schoenhagen P, Balog C, Shishehbor M, Zhitnik J , Churchill T, Magyar W, Kapadia S,Nissen SE. Beta-Blockers and Progression of Coronary Atherosclerosis: A Meta-Analysis from Four Intravascular Ultrasound Trial. Circulation 2006;114 (suppl): II-796. 2006 American Heart Association Scientific Sessions.

  35. Sipahi I, Tuzcu EM, Nicholls SJ, Schoenhagen P, Wolski KE, Balog C, Magyar WA, Winkhart A, Colagiovanni A, Kapadia S, Nissen SE. Progressiono f Coronary Atherosclerosis: DoACE Inhibitors Make a Difference? Circulation 2006;114 (suppl): II-796. 2006 American Heart Association Scientific Sessions.

  36. Tekin G, Tekin A, Canatar T, Sipahi I, Unsal A, Erol T,  Demircan S, Yigit F, Katircibasi T, Kocum HT, Sezgin AT, Baltali M, Muderrisoglu H. Simvastatin Improves the Attenuated Heart Rate Recovery of Type 2 Diabetics. Circulation 2006;114 (suppl): II-849. 2006 American Heart Association Scientific Sessions.

  37. Sipahi I, Tuzcu EM, Nicholls SJ, Schoenhagen P, Wolski KE, Balog C, Andrews J, Fonk T, Magyar WA, Kapadia S, Nissen SE. Effect of Obesity on Progression of Coronary Atherosclerosis: Observations from Four Intravascular Ultrasound Trials. Circulation 2006;114 (suppl): II-886. 2006 American Heart Association Scientific Sessions.

  38.  Baris N, Sipahi I, Starling R, Hobbs R, Kapadia SR, Tuzcu EM. Increase in TIMI frame count in the first year after transplantation is associated with increased lon-term mortality in patinets with cardiac transplantation. Am J Transplant 2006 (suppl): 381. 2006 World Transplant Congress.

  39. Sipahi I, Tuzcu EM, Nicholls SJ, Moon K, Schoenhagen P, Wolski K , Grasso A, Magyar W, Crowe TD, Kapadia S, Nissen SE. Regression Of Coronary Atherosclerosis During Treatment With Statins: Does Age Make A Difference? J Am Coll Cardiol 2007;49(suppl A): 336A. American College of Cardiology Annual Scientific Sessions.

  40. Nicholls SJ, Sipahi I, Crowe TD, Raichlen J, Cain VA, Tuzcu EM, Nissen SE. Baseline Lipid Status Does Not Influence the Promotion of Coronary Atheroma Regression in Response to Use of High Dose Statin Therapy: Insights from ASTEROID. J Am Coll Cardiol 2007;49(suppl A): 365A. American College of Cardiology Annual Scientific Sessions.

  41. Nicholls SJ, Tuzcu EM, Sipahi I, Grasso A, Schoenhagen P, Hu T, Wolski K,  Crowe T, Desai M, Hazen SL, Kapadia S, Nissen SE. Statin Mediated Increases in HDL Cholesterol Promote Regression of Coronary Atherosclerosis: Insights from Intravascular Ultrasound . J Am Coll Cardiol 2007;49(suppl A): 365A. American College of Cardiology Annual Scientific Sessions.

  42. Grasso AW, Nicholls SJ, Hu T, Sipahi I,  Raichlen J, cain VA, Tuzcu EM, Brener SJ, Nissen SE. Intensive Lowering of the LDL-C/HDL-C Ratio With High Dose Statin Therapy Promotes Regression of Obstructive Coronary Artery Disease: Insights From ASTEROID. J Am Coll Cardiol 2007;49(suppl A): 393A. American College of Cardiology Annual Scientific Sessions.

  43.  Angiotesin-Converting Enzyme Inhibitors Attenuate Age-related Progression of Cardiac Allograft Vasculopathy - A Serial Volumetric Intravascular Ultrasound Study. Moon KW, Sipahi I, Nicholls SJ, Schoenhagen P, Kalidindi SR, Kapadia SR, Starling RC, Hobbs RE, Erinc K, Magyar WA, Nissen SE, Tuzcu EM. Circulation 2007; 116: II-643. 2007 American Heart Association Scientific Sessions.

  44. Does the Presence of the Metabolic Syndrome Accelerate Progression of Cardiac Allograft Vasculopathy: A Serial Volumetric Intravascular Ultrasound Study . Moon KW, Nicholls SJ, Sipahi I, Schoenhagen P, Kapadia SR, Starling RC, Hobbs RE, Magyar WA, Nissen SE, Tuzcu EM. J Am Coll Cardiol 2008;51(suppl 1): A79. American College of Cardiology Annual Scientific Sessions.

  45. Mishra P, Sipahi I, Taylor SE, Boxer R, Fang JC. Effect of ACE Inhibitors on the Incidence of Cancer: Meta-Analysis of Randomized Controlled Trials. 14th Annual Scientific meeting of the Heart Failure Society of America (September 12-15, 2010, San Diego, CA) J Card Failure 2010.

  46. Sipahi I , Carrigan TP, Rowland DY, Stambler BS, Fang JC.  Impact of QRS Duration on Clinical Event Reduction with Cardiac Resynchronization Therapy: A Meta-Analysis of Randomized Controlled Trials. Circulation 2010;122:A15813. 2010 American Heart Association Scientific Sessions.

  47. Swaminathan AC, Sipahi I, Simon DI, Fang JC. Effect of Anti-Hypertensive Therapy on the Incidence of Stroke in Patients with Prehypertensive Blood Pressure Levels: Meta-Analysis of Placebo Controlled Randomized Trials.  J Am Coll Cardiol 2011;57(14):E611.

  48. Issa M, Sipahi I, Chaudhry SP, Fang JC. Impact of Ejection Fraction on Survival Benefit with Implantable Cardioverter-Defibrillator Therapy. J Am Coll Cardiol 2011;57(14):E37.

  49. Huck  K , Close, T, Cuevas C, Eck C, Oakleaf, K, Plank  T, ,Koppleman C,  Kikano G, Sipahi I,  Fang JC . A Home Care Program Early After Heart Failure Hospitalization Decreases All-Cause 30 Day Readmission Rates. Circulation  2011;124 (21): A15516 .

  50. Dağdelen S, Buturak A., Görgülü Ş, Norgaz T, Değirmencioğlu A, Akyol A, Sipahi I, Değirmenci Y. Clinical Comparison of the Sixth Hour-Early Discharge versus Overnight Observation after Elective Transradial Coronary Intervention: A Randomized Study. J Am Coll Cardiol  2013; 62 (18, Supplement 2): C234-5.

  51. Sipahi I, Akay MH, Dagdelen S, Blitz A, Alhan C. Evidence for Mortality Benefit of Bypass Surgery over Stenting Before Publication of the SYNTAX and FREEDOM Trials: Value of Meta-Analyses. Circulation  2013.